Mengyuan Li

8.5k total citations · 2 hit papers
219 papers, 5.5k citations indexed

About

Mengyuan Li is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mengyuan Li has authored 219 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 59 papers in Immunology and 40 papers in Oncology. Recurrent topics in Mengyuan Li's work include Cancer Immunotherapy and Biomarkers (18 papers), Ferroptosis and cancer prognosis (15 papers) and Inflammasome and immune disorders (13 papers). Mengyuan Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Ferroptosis and cancer prognosis (15 papers) and Inflammasome and immune disorders (13 papers). Mengyuan Li collaborates with scholars based in China, United States and Canada. Mengyuan Li's co-authors include Xiaosheng Wang, Lin Li, Yue Zhang, Zehang Jiang, Zhixian Liu, Zeinab Abdelrahman, Chunxiao Li, Junjie Wang, Yuhan Yang and Ping Jiang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mengyuan Li

205 papers receiving 5.5k citations

Hit Papers

Expression of the SARS-Co... 2020 2026 2022 2024 2020 2023 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengyuan Li China 32 1.9k 1.2k 1.1k 953 799 219 5.5k
Luca Falzone Italy 37 2.5k 1.3× 593 0.5× 1.2k 1.1× 631 0.7× 1.3k 1.6× 101 5.3k
Xiang Chen China 40 2.4k 1.2× 801 0.7× 947 0.9× 659 0.7× 1.0k 1.3× 276 6.3k
Wei Zhang China 34 2.0k 1.1× 475 0.4× 847 0.8× 754 0.8× 831 1.0× 264 4.6k
Ke Zhang China 39 3.0k 1.6× 483 0.4× 959 0.9× 503 0.5× 1.2k 1.5× 255 6.0k
Hui Li China 45 3.1k 1.6× 693 0.6× 816 0.7× 804 0.8× 1.6k 2.0× 302 7.5k
Shemin Lu China 36 1.9k 1.0× 938 0.8× 419 0.4× 934 1.0× 798 1.0× 164 5.0k
Guanmin Jiang China 28 2.4k 1.3× 1.1k 0.9× 717 0.6× 473 0.5× 1.3k 1.6× 54 4.7k
Lin Li China 38 3.3k 1.7× 512 0.4× 1.0k 0.9× 574 0.6× 1.8k 2.2× 244 6.6k
Ze‐Guang Han China 47 4.3k 2.3× 1.4k 1.2× 1.3k 1.1× 729 0.8× 1.7k 2.1× 234 8.9k

Countries citing papers authored by Mengyuan Li

Since Specialization
Citations

This map shows the geographic impact of Mengyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyuan Li more than expected).

Fields of papers citing papers by Mengyuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyuan Li. The network helps show where Mengyuan Li may publish in the future.

Co-authorship network of co-authors of Mengyuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengyuan Li. A scholar is included among the top collaborators of Mengyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengyuan Li. Mengyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chunxiao, Ping Jiang, Junjie Wang, et al.. (2025). Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation. Molecular Cancer. 24(1). 34–34. 9 indexed citations
2.
Li, Mengyuan, Weiying Li, Juanjuan Sun, et al.. (2025). The Experience of Adults' Family Caregivers Using Home Care Services: A Scoping Review. Journal of Advanced Nursing. 81(9). 5706–5717.
3.
Hou, Yuxin, et al.. (2025). TLR4-mediated endoplasmic reticulum stress regulates pyroptosis in macrophages infected with the Bacillus Calmette-Guérin mycobacterial. International Immunopharmacology. 152. 114346–114346. 1 indexed citations
4.
Zhang, Mingming, Mengyuan Li, Wei Huang, et al.. (2024). NCOA4-mediated ferritinophagy participates in cadmium-triggered ferroptosis in spermatogonia. Toxicology. 505. 153831–153831. 14 indexed citations
5.
Wang, Xiao, Yuqing Yang, Wenguang Yang, et al.. (2024). A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response. Veterinary Microbiology. 297. 110194–110194. 1 indexed citations
6.
Jia, Yanfeng, Haoming Fan, Juan Fu, et al.. (2024). Soil compaction due to agricultural machinery impact: A systematic review. Land Degradation and Development. 35(10). 3256–3273. 29 indexed citations
7.
Zhao, Zhiwei, et al.. (2023). Weed control performance of different sowing modes in organic wheat production. Crop Protection. 175. 106473–106473. 2 indexed citations
8.
Zhao, Haiyan, et al.. (2023). E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer. Cellular Signalling. 113. 110961–110961. 5 indexed citations
9.
10.
Zhao, Yan, Yongbo Zhao, Ziyi Zhang, et al.. (2023). No association of vaccination with inactivated COVID‐19 vaccines before conception with pregnancy complications and adverse birth outcomes: A cohort study of 5457 Chinese pregnant women. Journal of Medical Virology. 95(4). e28735–e28735. 3 indexed citations
11.
Li, Mengyuan, Dong Liu, Dušan Lošić, et al.. (2023). Efficient Ag+ adsorption of in-vivo thiol-functionalized diatoms and its application for sensitive surface-enhanced Raman scattering. Chemical Engineering Journal. 479. 147751–147751. 7 indexed citations
12.
13.
Qiu, Kexin, et al.. (2023). CXCL5 Promotes Acetaminophen-Induced Hepatotoxicity by Activating Kupffer Cells. International Journal of Molecular Sciences. 24(15). 12180–12180. 3 indexed citations
14.
Hao, Yuanyuan, Panpan Chen, Mengyuan Li, et al.. (2023). Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling. Frontiers of Medicine. 18(1). 128–146. 11 indexed citations
15.
Wang, Jiao, Qing Yang, Dandan Wang, Mengyuan Li, & Ningning Zhang. (2022). Case Report: Gastric-Type Endocervical Adenocarcinoma Mimicking Submucosal Myoma Under Hysteroscopy. Frontiers in Medicine. 9. 845445–845445. 1 indexed citations
16.
Li, Mengyuan, Yi‐Xin Huo, & Shuyuan Guo. (2022). CRISPR-Mediated Base Editing: From Precise Point Mutation to Genome-Wide Engineering in Nonmodel Microbes. Biology. 11(4). 571–571. 14 indexed citations
17.
Li, Mengyuan, Jian Zhao, Xue Wen, et al.. (2021). Relationship between intact parathyroid hormone and all-cause death, cardiovascular events, and ectopic calcification in patients with diabetic kidney disease: A retrospective study. Diabetes Research and Clinical Practice. 177. 108926–108926. 2 indexed citations
18.
Li, Mengyuan, et al.. (2020). KALRN mutations promote antitumor immunity and immunotherapy response in cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000293–e000293. 16 indexed citations
19.
Lai, Chong, Wenjie Sun, Xiaosheng Wang, et al.. (2019). RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer. Pathology - Research and Practice. 215(8). 152453–152453. 12 indexed citations
20.
Li, Ning, Yeming Yang, Qiang Qiu, et al.. (2018). Tmem30a Plays Critical Roles in Ensuring the Survival of Hematopoietic Cells and Leukemia Cells in Mice. American Journal Of Pathology. 188(6). 1457–1468. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026